XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $808,000 | -1.1% | 79,539 | -38.6% | 0.22% | -35.4% |
Q4 2018 | $817,000 | -52.2% | 129,539 | 0.0% | 0.34% | -46.1% |
Q3 2018 | $1,710,000 | -25.3% | 129,539 | -47.9% | 0.63% | -21.6% |
Q2 2018 | $2,289,000 | +36.7% | 248,823 | -27.2% | 0.81% | +25.4% |
Q1 2018 | $1,675,000 | +73.0% | 341,884 | 0.0% | 0.64% | +113.6% |
Q4 2017 | $968,000 | -12.7% | 341,884 | -9.0% | 0.30% | -3.5% |
Q3 2017 | $1,109,000 | -6.3% | 375,784 | 0.0% | 0.31% | -21.6% |
Q2 2017 | $1,184,000 | -22.3% | 375,784 | -1.3% | 0.40% | +38.1% |
Q1 2017 | $1,523,000 | -50.6% | 380,784 | -5.0% | 0.29% | -57.1% |
Q4 2016 | $3,085,000 | -7.7% | 400,677 | -2.9% | 0.67% | -22.8% |
Q3 2016 | $3,341,000 | +29.7% | 412,479 | -5.5% | 0.87% | +60.3% |
Q2 2016 | $2,575,000 | -15.6% | 436,384 | 0.0% | 0.54% | 0.0% |
Q1 2016 | $3,050,000 | -13.1% | 436,384 | 0.0% | 0.54% | -18.4% |
Q4 2015 | $3,509,000 | -4.5% | 436,384 | -1.9% | 0.67% | -12.4% |
Q3 2015 | $3,673,000 | -28.4% | 444,655 | 0.0% | 0.76% | +17.4% |
Q2 2015 | $5,127,000 | -32.8% | 444,655 | 0.0% | 0.65% | -31.6% |
Q1 2015 | $7,626,000 | -13.2% | 444,655 | 0.0% | 0.95% | -6.5% |
Q4 2014 | $8,782,000 | – | 444,655 | – | 1.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |